Presbyopia: Clinical Trials

333 trials for Presbyopia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

229 completed, 40 unknown, 18 recruiting, 16 terminated. 211 Not applicable, 30 Phase 3, 20 Phase 2, 14 Phase 4, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable211Completed 153, Unknown 15, Not yet recruiting 11, Recruiting 11, Terminated 9, Active not recruiting 6, Withdrawn 5, Enrolling by invitation 1
Phase 330Completed 22, Unknown 6, Recruiting 1, Terminated 1
Phase 220Completed 16, Terminated 2, Recruiting 1, Withdrawn 1
Phase 414Unknown 6, Completed 4, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 17Completed 4, Unknown 2, Terminated 1
Early Phase 11Unknown 1

Follow this condition Literature Review of Presbyopia trials Research Report on Presbyopia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Evaluation of Visual Performance, Spectacle Independence, and Patient Satisfaction With TECNIS PureSee Mini-Monovision and TECNIS PureSee-TECNIS Odyssey Mix-Match
TECNIS PureSee IOL (Model DEN00V/DET150), TECNIS Odyssey IOL (Model DRN00V/DRT150) - Presbyopia Correction, Presbyopia
Phase 4Not yet recruitingDr. Daniel H. Chang, MD682026-10-012026-10-06
Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus
NOA lens type 1, NOA lens type 2 - Keratoconus, Presbyopia
Not applicableRecruitingAzalea Vision162026-09-282026-10-13
Evaluation of Functional Superiority of the Morrow eProgressive
3 weeks wearing of study device instead of their current wearing solution - Presbyopia
Not applicableRecruitingMorrow Eyewear502026-09-242026-10-16
Volumetric Visual Fields at Different Distances in Presbyopic Patients Using Occupational (PC-133 and PC-200) and General-Purpose Progressive Addition Lenses
OPAL PC 133 assessment, OPAL PC 200 assessment, PAL assessment - Presbyopia
Not applicableRecruitingUniversity of Seville282026-06-082026-10-15
VisDura VisAbility™ Micro Insert System Pre-market Clinical Trial
VisAbility™ Micro Insert System - Presbyopia
Not applicableRecruitingVisDura, Inc.332026-06-022026-10-15
Contact Lens Trial Fitting Experience
Lens A ( stenfilcon A ) - Presbyopia
Not applicableNot yet recruitingCooperVision International Limited (CVIL)252026-05-312026-05-22
Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses
DAILIES TOTAL1 Multifocal (delefilcon A) - Contact Lens Comfort and Successful Refitting, Presbyopia
Not applicableRecruitingGordon Schanzlin New Vision302026-05-202026-06-11
Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individuals With Presbyopia: A Randomized Clinical Study
Laser Blended Vision LASIK, Traditional Monovision LASIK - Presbyopia, Refractive Error
Not applicableRecruitingZhongshan Ophthalmic Center, Sun Yat-sen University1002026-05-122026-07-07
Contralateral Claims Study of Clareon Vivity Pro
Clareon Vivity Pro IOL, Clareon Vivity IOL, TECNIS PureSee IOL - Aphakia, Presbyopia
Not applicableActive not recruitingAlcon Research1652026-04-282026-10-13
Clinical Performance of Verofilcon A Toric Contact Lenses
Total 30 multi foric contact lenses - Contact Lenses, Presbyopia
Not applicableRecruitingSouthern College of Optometry322026-04-012026-05-14
Performance of Two Daily Disposable Multifocal Contact Lenses
Lens A (kalfilcon A), Lens B (stenfilcon A) - Presbyopia
Not applicableRecruitingCooperVision International Limited (CVIL)352026-02-242026-04-08
Comfort and Vision With TOTAL30 Multifocal Lenses
TOTAL30 Multifocal - Myopia, Presbyopia
CompletedScripps Poway Eyecare and Optometry322026-02-052026-09-04
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
Multifocal contact lenses, Spherical contact lenses - Presbyopia Correction, Presbyopia
Not applicableActive not recruitingOhio State University302025-12-082026-09-24
Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs
Phacoemulsification with EDOF IOLs - Presbyopia
RecruitingDemocritus University of Thrace1002025-10-152026-02-24
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
Clareon PanOptix Pro/Pro Toric Trifocal IOL, Phacoemulsification - Aphakia, Presbyopia
Not applicableCompletedAlcon Research1102025-10-142026-10-19
Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients.
Quantitative refractive crosslinking - Presbyopia
Not applicableNot yet recruitingTECLens, Inc.252025-09-302025-10-06
Volumetric Visual Fields at Intermediate and Near Distances in Presbyopic Patients Using Occupational and General-Purpose Progressive Addition Lenses
OPAL PC assesment, OPAL Office assessment, PAL assesment - Presbyopia
Not applicableRecruitingUniversity of Seville262025-09-292026-10-15
The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia
Esculin and Digitalisglycosides Eye Drops, Normal saline solution - Presbyopia
Phase 4CompletedShanxi Eye Hospital622025-09-042026-03-25
Quantitative Refractive Crosslinking in Presbyopia Aged Patients
Quantitative refractive crosslinking - Presbyopia
Not applicableNot yet recruitingTECLens, Inc.252025-08-312025-08-29
Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic
cataract surgery, implantation of device IOL FG-80030.1 - Intraocular Lens, Cataract
Not applicableRecruitingZ Optics, Inc.602025-08-072026-09-18

Showing 20 of 333. Sign in to see all of them.

Narrower conditions

Cataract (78)  ·  Myopia (53)  ·  Refractive Errors (43)  ·  Astigmatism (28)  ·  Hyperopia (28)  ·  Aphakia (13)  ·  Pseudophakia (9)  ·  Eye Diseases (7)  ·  Asthenopia (4)  ·  Glaucoma (3)  ·  Patient Satisfaction (3)  ·  Vision, Low (3)  ·  Diabetic Retinopathy (2)  ·  Dry Eye Syndromes (2)

Broader conditions

Eye Diseases (326)  ·  Refractive Errors (290)  ·  Lens Diseases (80)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Signs and Symptoms (15)  ·  Nervous System Diseases (8)  ·  Neurologic Manifestations (6)  ·  Sensation Disorders (5)  ·  Behavior (4)  ·  Health Behavior (3)  ·  Lacrimal Apparatus Diseases (3)  ·  Ocular Hypertension (3)  ·  Treatment Adherence and Compliance (3)  ·  Vision Disorders (3)  ·  Cardiovascular Diseases (2)

Interventions

Cataract Extraction (16)  ·  Brimonidine Tartrate (12)  ·  Pilocarpine (9)  ·  Macrophage Colony-Stimulating Factor (6)  ·  Phacoemulsification (6)  ·  aceclidine (5)  ·  Control Groups (4)  ·  Eyeglasses (4)  ·  Carbachol (3)  ·  Contact Lenses (3)  ·  Keratomileusis, Laser In Situ (3)  ·  Lenses, Intraocular (3)  ·  Mitomycin (3)  ·  Oxymetazoline (3)  ·  Contrast Sensitivity (2)

Sponsors

Alcon Research (36)  ·  Democritus University of Thrace (20)  ·  CooperVision, Inc. (16)  ·  AcuFocus, Inc. (11)  ·  Beaver-Visitec International, Inc. (10)  ·  CIBA VISION (9)  ·  Johnson & Johnson Vision Care, Inc. (9)  ·  Technolas Perfect Vision GmbH (9)  ·  LENZ Therapeutics, Inc (8)  ·  Allergan (7)  ·  Bausch & Lomb Incorporated (6)  ·  CooperVision International Limited (CVIL) (6)  ·  Orasis Pharmaceuticals Ltd. (6)  ·  ACE Vision Group, Inc. (4)  ·  VisDura, Inc. (4)

Countries

United States (131)  ·  Greece (20)  ·  United Kingdom (16)  ·  Spain (15)  ·  China (13)  ·  Canada (12)  ·  Philippines (12)  ·  Germany (11)  ·  Australia (10)  ·  France (10)  ·  South Korea (10)  ·  Belgium (7)  ·  Czechia (6)  ·  Japan (6)  ·  Mexico (6)

Top investigators

Georgios Labiris, MD, PhD (13)  ·  Andrew Sacco (3)  ·  Katherine Bickle (3)  ·  Kris Gambelin, BS (3)  ·  Nathan G Congdon, MD, MPH (3)  ·  Perry Binder, MD (3)  ·  Robert Edward Ang, MD (3)  ·  Tae-Young Chung, PhD (3)  ·  Alisyn Facemire, BA (2)  ·  Cesar Alejandro S Galeana, MD (2)

Results publications

PMID 17269242, PMID 19537363, PMID 19603619, PMID 33102611, PMID 18494342, PMID 26903524, PMID 30907859, PMID 34866900, PMID 38216351, PMID 16722483, PMID 16850290, PMID 17159450, PMID 18500082, PMID 18803826, PMID 18811107, PMID 21217408, PMID 21508106, PMID 22105801, PMID 22513631, PMID 23109740, PMID 23430147, PMID 24784872, PMID 25185255, PMID 26190438, PMID 26804761, PMID 27107029, PMID 27792408, PMID 28116335, PMID 28676280, PMID 28812042, PMID 29514611, PMID 30046464, PMID 30049615, PMID 30451806, PMID 30460857, PMID 30587911, PMID 32050231, PMID 32449445, PMID 32669090, PMID 32982164, PMID 34588763, PMID 34643894, PMID 34855038, PMID 35238902, PMID 35282170, PMID 35297798, PMID 35848990, PMID 35862830, PMID 35948879, PMID 36071311

NIH funding

U01EB023048 (1)